244 papers found
Refreshing results…
Supplementary Figure 5
HIF-2α Suppresses p53 to Enhance the Stemness and Regenerative Potential of Human Embryonic Stem Cells
Figure S1
Figure S4
Figure S6
Figure S2
Figure S3
Use of nano-immuno assay to generate rapid, quantitative nanoscale proteomic profiling of the hypoxia pathway in renal cell carcinoma clinical specimens.
Twist1 Suppresses Senescence Programs and Thereby Accelerates and Maintains Mutant Kras-Induced Lung Tumorigenesis
Abstract 1280: Nano-scale phospho-proteomic analysis to define diagnostic signatures and biomarkers of therapeutic activity in cancer
Abstract 2975: Transgenic mouse model of Twist1-induced metastasis reveals genes highly prognostic for human hepatocellular carcinoma
Abstract 4879: Distinct roles of p53 and p19ARF in MYC-dependent tumor oncogene addiction
Abstract LB-443: The Simple Western rapidly generates quantitative profiles of MAPK and PI3K proteins in clinical specimens
“Picolog,” a Synthetically-Available Bryostatin Analog, Inhibits Growth of MYC-Induced Lymphoma In Vivo
High throughput automated chromatin immunoprecipitation as a platform for drug screening and antibody validation†,‡
Loss of Dnmt3b function upregulates the tumor modifier Ment and accelerates mouse lymphomagenesis
A Novel Nano-Immunoassay (NIA) Reveals Inhibition of PI3K and MAPK Pathways in CD34+ Bone Marrow Cells of Patients with Myelodysplastic Syndrome (MDS) Treated with the Multi-Kinase Inhibitor On 01910.Na (Rigosertib),
Survival and Death Signals Can Be Used to Predict when Oncogene Inactivation Will Elicit Oncogene Addiction
Lymphomas that recur after MYC suppression continue to exhibit oncogene addiction
Treatment of Higher Risk Myelodysplastic Syndrome Patients Unresponsive to Hypomethylating Agents with ON 01910.Na
Missing publications? Read more about our data sources.